IL71232A - פלסמיד רקומביננטי המקודד פוליפפטיד של איטרפרון-c של בני אדם, תהליך להכנתו, ומיקרואורגניזמים המכילים אותו - Google Patents

פלסמיד רקומביננטי המקודד פוליפפטיד של איטרפרון-c של בני אדם, תהליך להכנתו, ומיקרואורגניזמים המכילים אותו

Info

Publication number: IL71232A
Authority: IL; Israel
Prior art keywords: dna; recombinant plasmid; escherichia coli; polypeptide; plasmid
Prior art date: 1983-03-14

Application number

IL7123284A

Other languages

English (en)

Original Assignee

Kyowa Hakko Kogyo Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-03-14

Filing date

1984-03-14

Publication date

1995-07-31

1984-03-14 Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk

1995-07-31 Publication of IL71232A publication Critical patent/IL71232A/he

Links

239000013612 plasmid Substances 0.000 title claims description 51
101000599940 Homo sapiens Interferon gamma Proteins 0.000 title claims description 23
238000000034 method Methods 0.000 title claims description 18
244000005700 microbiome Species 0.000 title claims description 11
102000043557 human IFNG Human genes 0.000 title claims description 5
238000004519 manufacturing process Methods 0.000 title description 5
241000588724 Escherichia coli Species 0.000 claims description 22
239000012634 fragment Substances 0.000 claims description 21
108010074328 Interferon-gamma Proteins 0.000 claims description 19
QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 8
QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 8
229920001184 polypeptide Polymers 0.000 claims description 7
102000004196 processed proteins & peptides Human genes 0.000 claims description 7
108090000765 processed proteins & peptides Proteins 0.000 claims description 7
238000012258 culturing Methods 0.000 claims description 6
102000008070 Interferon-gamma Human genes 0.000 claims description 5
210000004748 cultured cell Anatomy 0.000 claims description 4
125000003275 alpha amino acid group Chemical group 0.000 claims 2
108020004414 DNA Proteins 0.000 description 65
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 22
238000006243 chemical reaction Methods 0.000 description 18
TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 14
239000000243 solution Substances 0.000 description 14
238000000246 agarose gel electrophoresis Methods 0.000 description 13
230000029087 digestion Effects 0.000 description 12
102100037850 Interferon gamma Human genes 0.000 description 11
239000011780 sodium chloride Substances 0.000 description 11
210000004027 cell Anatomy 0.000 description 10
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 8
238000010276 construction Methods 0.000 description 8
239000002609 medium Substances 0.000 description 8
239000000203 mixture Substances 0.000 description 8
239000000047 product Substances 0.000 description 8
VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 7
229910001629 magnesium chloride Inorganic materials 0.000 description 7
238000000746 purification Methods 0.000 description 6
150000001413 amino acids Chemical group 0.000 description 5
238000007796 conventional method Methods 0.000 description 5
102000012410 DNA Ligases Human genes 0.000 description 4
108010061982 DNA Ligases Proteins 0.000 description 4
239000013604 expression vector Substances 0.000 description 4
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
241001131785 Escherichia coli HB101 Species 0.000 description 3
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
108010050904 Interferons Proteins 0.000 description 3
102000014150 Interferons Human genes 0.000 description 3
HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
238000010367 cloning Methods 0.000 description 3
229960001484 edetic acid Drugs 0.000 description 3
238000005516 engineering process Methods 0.000 description 3
239000008103 glucose Substances 0.000 description 3
239000013600 plasmid vector Substances 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
239000000126 substance Substances 0.000 description 3
239000006228 supernatant Substances 0.000 description 3
239000013598 vector Substances 0.000 description 3
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
108010017826 DNA Polymerase I Proteins 0.000 description 2
102000004594 DNA Polymerase I Human genes 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
239000004472 Lysine Substances 0.000 description 2
102000016943 Muramidase Human genes 0.000 description 2
108010014251 Muramidase Proteins 0.000 description 2
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108020004511 Recombinant DNA Proteins 0.000 description 2
108091081024 Start codon Proteins 0.000 description 2
241000700605 Viruses Species 0.000 description 2
239000002253 acid Substances 0.000 description 2
210000004102 animal cell Anatomy 0.000 description 2
239000007853 buffer solution Substances 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
239000002299 complementary DNA Substances 0.000 description 2
OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
230000000694 effects Effects 0.000 description 2
229940088598 enzyme Drugs 0.000 description 2
239000000284 extract Substances 0.000 description 2
238000000605 extraction Methods 0.000 description 2
239000012530 fluid Substances 0.000 description 2
230000008014 freezing Effects 0.000 description 2
238000007710 freezing Methods 0.000 description 2
ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
229940079322 interferon Drugs 0.000 description 2
210000000265 leukocyte Anatomy 0.000 description 2
239000006166 lysate Substances 0.000 description 2
229960000274 lysozyme Drugs 0.000 description 2
239000004325 lysozyme Substances 0.000 description 2
235000010335 lysozyme Nutrition 0.000 description 2
229910052943 magnesium sulfate Inorganic materials 0.000 description 2
230000008018 melting Effects 0.000 description 2
238000002844 melting Methods 0.000 description 2
108020004999 messenger RNA Proteins 0.000 description 2
229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
CJWXCNXHAIFFMH-AVZHFPDBSA-N n-[(2s,3r,4s,5s,6r)-2-[(2r,3r,4s,5r)-2-acetamido-4,5,6-trihydroxy-1-oxohexan-3-yl]oxy-3,5-dihydroxy-6-methyloxan-4-yl]acetamide Chemical compound C[C@H]1O[C@@H](O[C@@H]([C@@H](O)[C@H](O)CO)[C@@H](NC(C)=O)C=O)[C@H](O)[C@@H](NC(C)=O)[C@@H]1O CJWXCNXHAIFFMH-AVZHFPDBSA-N 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
150000007523 nucleic acids Chemical class 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
239000011782 vitamin Substances 0.000 description 2
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
FPXCYGSFMNEBPA-UHFFFAOYSA-N 1h-indole;prop-2-enoic acid Chemical compound OC(=O)C=C.C1=CC=C2NC=CC2=C1 FPXCYGSFMNEBPA-UHFFFAOYSA-N 0.000 description 1
WIGIZIANZCJQQY-UHFFFAOYSA-N 4-ethyl-3-methyl-N-[2-[4-[[[(4-methylcyclohexyl)amino]-oxomethyl]sulfamoyl]phenyl]ethyl]-5-oxo-2H-pyrrole-1-carboxamide Chemical compound O=C1C(CC)=C(C)CN1C(=O)NCCC1=CC=C(S(=O)(=O)NC(=O)NC2CCC(C)CC2)C=C1 WIGIZIANZCJQQY-UHFFFAOYSA-N 0.000 description 1
229930024421 Adenine Natural products 0.000 description 1
GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
108020004705 Codon Proteins 0.000 description 1
241000557626 Corvus corax Species 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
101900234631 Escherichia coli DNA polymerase I Proteins 0.000 description 1
241001646716 Escherichia coli K-12 Species 0.000 description 1
239000005715 Fructose Substances 0.000 description 1
229930091371 Fructose Natural products 0.000 description 1
RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
102100034523 Histone H4 Human genes 0.000 description 1
101000999325 Homo sapiens Cobalamin binding intrinsic factor Proteins 0.000 description 1
101001067880 Homo sapiens Histone H4 Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
229930195725 Mannitol Natural products 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
125000001429 N-terminal alpha-amino-acid group Chemical group 0.000 description 1
101100205180 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) leu-6 gene Proteins 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
239000004098 Tetracycline Substances 0.000 description 1
240000008042 Zea mays Species 0.000 description 1
235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
235000002017 Zea mays subsp mays Nutrition 0.000 description 1
230000003213 activating effect Effects 0.000 description 1
239000013543 active substance Substances 0.000 description 1
229960000643 adenine Drugs 0.000 description 1
238000005273 aeration Methods 0.000 description 1
125000000539 amino acid group Chemical group 0.000 description 1
210000001691 amnion Anatomy 0.000 description 1
229960000723 ampicillin Drugs 0.000 description 1
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
238000000137 annealing Methods 0.000 description 1
230000000259 anti-tumor effect Effects 0.000 description 1
230000002155 anti-virotic effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
AIYUHDOJVYHVIT-UHFFFAOYSA-M caesium chloride Chemical compound [Cl-].[Cs+] AIYUHDOJVYHVIT-UHFFFAOYSA-M 0.000 description 1
229940041514 candida albicans extract Drugs 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
229960005091 chloramphenicol Drugs 0.000 description 1
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 1
238000003776 cleavage reaction Methods 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
235000005822 corn Nutrition 0.000 description 1
238000005520 cutting process Methods 0.000 description 1
XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
229940104302 cytosine Drugs 0.000 description 1
SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 1
SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 1
RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 1
HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 1
NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 1
238000000432 density-gradient centrifugation Methods 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
238000000855 fermentation Methods 0.000 description 1
230000004151 fermentation Effects 0.000 description 1
210000002950 fibroblast Anatomy 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
239000000411 inducer Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
230000000977 initiatory effect Effects 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
230000001320 lysogenic effect Effects 0.000 description 1
210000002540 macrophage Anatomy 0.000 description 1
239000000594 mannitol Substances 0.000 description 1
235000010355 mannitol Nutrition 0.000 description 1
235000013372 meat Nutrition 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
235000015097 nutrients Nutrition 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
102000004169 proteins and genes Human genes 0.000 description 1
230000036647 reaction Effects 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
238000011160 research Methods 0.000 description 1
230000007017 scission Effects 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000003756 stirring Methods 0.000 description 1
229960002180 tetracycline Drugs 0.000 description 1
229930101283 tetracycline Natural products 0.000 description 1
235000019364 tetracycline Nutrition 0.000 description 1
150000003522 tetracyclines Chemical class 0.000 description 1
230000002463 transducing effect Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
150000005691 triesters Chemical class 0.000 description 1
239000012137 tryptone Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
150000003722 vitamin derivatives Chemical class 0.000 description 1
239000012138 yeast extract Substances 0.000 description 1

Landscapes

Chemically Coating (AREA)
Preventing Corrosion Or Incrustation Of Metals (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

IL7123284A 1983-03-14 1984-03-14 פלסמיד רקומביננטי המקודד פוליפפטיד של איטרפרון-c של בני אדם, תהליך להכנתו, ומיקרואורגניזמים המכילים אותו IL71232A (he)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP58042022A JPS59170251A (ja)	1983-03-14	1983-03-14	鉛蓄電池用鉛合金素材の製造法

Publications (1)

Publication Number	Publication Date
IL71232A true IL71232A (he)	1995-07-31

Family

ID=12624538

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL7123284A IL71232A (he)	1983-03-14	1984-03-14	פלסמיד רקומביננטי המקודד פוליפפטיד של איטרפרון-c של בני אדם, תהליך להכנתו, ומיקרואורגניזמים המכילים אותו

Country Status (2)

Country	Link
JP (1)	JPS59170251A (he)
IL (1)	IL71232A (he)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03153879A (ja) *	1989-11-13	1991-07-01	Okuno Seiyaku Kogyo Kk	置換型無電解錫又は半田めっき方法
CN113029922B (zh) *	2021-02-26	2022-07-19	湖北双登润阳新能源有限公司	一种胶体蓄电池正极板栅合金及其腐蚀测试方法

1983
- 1983-03-14 JP JP58042022A patent/JPS59170251A/ja active Pending
1984
- 1984-03-14 IL IL7123284A patent/IL71232A/he not_active IP Right Cessation

Also Published As

Publication number	Publication date
JPS59170251A (ja)	1984-09-26

Legal Events

Date	Code	Title	Description
1996-06-18	KB	Patent renewed
1999-03-12	RH	Patent void

Publication	Publication Date	Title
EP0152613B1 (en)	1991-03-20	Novel promoter
EP0051873B1 (en)	1989-09-27	Hybrid human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them
US4678751A (en)	1987-07-07	Hybrid human leukocyte interferons
EP0083069B1 (en)	1987-09-16	Recombinant plasmid containing human interferon-beta gene
EP0170917B1 (en)	1991-05-29	Novel human interferon-gamma polypeptide derivative
US4456748A (en)	1984-06-26	Hybrid human leukocyte interferons
US4530901A (en)	1985-07-23	Recombinant DNA molecules and their use in producing human interferon-like polypeptides
NO164037B (no)	1990-05-14	Fremgangsm te ved fremstilling av et polypeptid av ron alfa (ifnalfa)-type.
GB2107718A (en)	1983-05-05	Human immune interferon
EP0146944B1 (en)	1993-03-24	Novel human interferon- polypeptide derivative
EP0121157B1 (en)	1989-06-14	Novel human interferon-gamma polypeptide
EP0128467A1 (en)	1984-12-19	Polypeptides having interferon activity
CA1214126A (en)	1986-11-18	Method for protecting a bacterium from a naturally occurring bacteriophage
EP0062971B1 (en)	1990-03-07	Genetically modified microorganisms
IL71232A (he)	1995-07-31	פלסמיד רקומביננטי המקודד פוליפפטיד של איטרפרון-c של בני אדם, תהליך להכנתו, ומיקרואורגניזמים המכילים אותו
EP0121569B1 (en)	1990-08-22	Novel vector
EP0126338A1 (en)	1984-11-28	Novel process for expressing a foreign gene
US4851512A (en)	1989-07-25	Novel human interleukin-2 polypeptide derivative
EP0064681A2 (en)	1982-11-17	Novel recombinant DNA
CA1300053C (en)	1992-05-05	Human interleukin-2 polypeptide derivative
Liu et al.	1987	Expression of a Pseudogene for Interferon-αL